We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$10.9B
AUM Growth
-$402M
Cap. Flow
+$2.15M
Cap. Flow %
0.02%
Top 10 Hldgs %
11.68%
Holding
955
New
28
Increased
567
Reduced
219
Closed
13

Sector Composition

Rank Sector Weight
1 Industrials 18.94%
2 Technology 17.5%
3 Healthcare 16.74%
4 Financials 12.68%
5 Consumer Discretionary 11.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COCO icon
201
Vita Coco
COCO
$3.76B
$19M 0.17%
681,266
+170,577
+33% +$4.52M
SN icon
202
SharkNinja
SN
$25.9B
$18.7M 0.17%
248,650
+16,500
+7% +$1.16M
KD icon
203
Kyndryl
KD
$2.77B
$18.6M 0.17%
707,283
+49,315
+7% +$1.18M
NOW icon
204
ServiceNow
NOW
$128B
$18.1M 0.17%
114,840
-1,210
-1% -$178K
SAIA icon
205
Saia
SAIA
$9.71B
$17.9M 0.16%
37,817
+5,013
+15% +$2.33M
PGNY icon
206
Progyny
PGNY
$1.97B
$17.8M 0.16%
622,835
-19,588
-3% -$590K
PJT icon
207
PJT Partners
PJT
$4.47B
$17.6M 0.16%
162,783
-4,939
-3% -$496K
HELE icon
208
Helen of Troy
HELE
$687M
$17.4M 0.16%
187,595
-6,719
-3% -$681K
ATRC icon
209
AtriCure
ATRC
$2.15B
$17.2M 0.16%
756,374
-42,696
-5% -$985K
TMO icon
210
Thermo Fisher Scientific
TMO
$221B
$17.1M 0.16%
30,966
-339
-1% -$194K
CRI icon
211
Carter's
CRI
$1.43B
$17M 0.16%
274,896
-528
-0.2% -$36.7K
CRNX icon
212
Crinetics Pharmaceuticals
CRNX
$8.96B
$16.9M 0.15%
377,663
-10,403
-3% -$480K
RARE icon
213
Ultragenyx Pharmaceutical
RARE
$2.61B
$16.7M 0.15%
406,519
+103,142
+34% +$4.4M
PWP icon
214
Perella Weinberg Partners
PWP
$1.31B
$16.2M 0.15%
999,325
-30,775
-3% -$465K
SNX icon
215
TD Synnex
SNX
$20.6B
$16M 0.15%
138,856
+9,595
+7% +$1.17M
OLLI icon
216
Ollie's Bargain Outlet
OLLI
$4.6B
$16M 0.15%
163,195
+11,295
+7% +$899K
BBSI icon
217
Barrett Business Services
BBSI
$743M
$15.9M 0.15%
485,116
+32,916
+7% +$1.04M
DHR icon
218
Danaher
DHR
$144B
$15.9M 0.15%
63,488
+13,485
+27% +$3.41M
IART icon
219
Integra LifeSciences
IART
$1.33B
$15.5M 0.14%
533,149
-166,366
-24% -$4.93M
ARQT icon
220
Arcutis Biotherapeutics
ARQT
$3.29B
$15.5M 0.14%
1,667,979
-53,274
-3% -$482K
RVLV icon
221
Revolve Group
RVLV
$1.68B
$15.3M 0.14%
961,502
+9,627
+1% +$184K
DCO icon
222
Ducommun
DCO
$3.06B
$14.5M 0.13%
249,665
-8,165
-3% -$456K
LEGH icon
223
Legacy Housing
LEGH
$682M
$14.5M 0.13%
630,592
+44,288
+8% +$975K
CTS icon
224
CTS Corp
CTS
$1.82B
$14.1M 0.13%
278,593
+18,989
+7% +$939K
DCI icon
225
Donaldson
DCI
$11.1B
$14.1M 0.13%
196,526
+13,800
+8% +$1.01M

Similar funds

GW&K Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, GW&K Investment Management held 955 positions worth $10.9B, down 3.5% from $11.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.3%. GW&K Investment Management opened 28 new positions and exited 13, leaving the 955-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • GW&K Investment Management's largest Q2 2024 buy was Simpson Manufacturing: 163,417 shares worth $27.5M.
  • GW&K Investment Management added most to Permian Resources in Q2 2024, an estimated $39.2M increase.
  • GW&K Investment Management's biggest Q2 2024 reduction was Rapid7, cutting an estimated $45.7M.
  • GW&K Investment Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $55K.
  • GW&K Investment Management's ten largest holdings make up 12% of its $10.9B portfolio in Q2 2024.
  • GW&K Investment Management opened 28 new positions and closed 13 in Q2 2024.
  • GW&K Investment Management's portfolio value fell 3.5% quarter-over-quarter to $10.9B.

Based on GW&K Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.